The African Institute for Mathematical Sciences-Next Einstein Initiative (AIMS-NEI) received a $66,000 investment from GlaxoSmithKline, Research & Development Ltd. (GSK R&D). The funds will be used for research in health care access, medical or scientific education, life sciences and progress in the prevention, treatment and management of disease.

“One of the goals of the AIMS is to create a productive environment for our continent’s brightest minds,” said AIMS President and CEO Thierry Zomahoun. “We also want to ensure our graduates have a chance to work in the best places to propel our continent.” 

The collaboration between AIMS-NEI and GSK R&D will be part of the AIMS industrial initiative (AIMS II) program with the goal of maximizing mathematical sciences as a contributor to Africa’s economy through human capital, knowledge transfer and applied research. It connects its graduates with for-profit, non-profit and government institutions that direct development.

AIMS II works with organizations to fill employment vacancies with proven talent. AIMS-NEI graduates have world-class training in mathematical sciences and applied research. They also train in communications and other professional skills to succeed in performance-driven organizations.

The AIMS-NEI and GSK R&D partnership cultivates applied research. The partnership is a result of the GSK Africa Non-communicable lab project which builds statistics capacity in sub Saharan Africa. It empowers recent graduates and alumni with internships in research labs for non-communicable disease projects in Africa.